Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men

Copeptin concentrations are not elevated in gestational diabetes mellitus

(2013) Mahmut Oncul et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Relative Atrial Natriuretic Peptide Deficiency and Inadequate Renin and Angiotensin II Suppression in Obese Hypertensive Men

(2013) Camilla L. Asferg et al.   HYPERTENSION

Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

(2012) S Enhörning et al.   INTERNATIONAL JOURNAL OF OBESITY

Impact of Body Mass Index and Waist Circumference on the Long-Term Risk of Diabetes Mellitus, Hypertension, and Cardiac Organ Damage

(2011) Michele Bombelli et al.   HYPERTENSION

Diabetes and Hypertension and Atherosclerotic Cardiovascular Disease

(2011) Christian Torp-Pedersen et al.   HYPERTENSION

Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure

(2011) Urban Alehagen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

(2011) Sofia Enhörning et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Copeptin and the Risk of Diabetes Mellitus

(2010) Sofia Enhörning et al.   CIRCULATION

Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring

(2009) Paolo Verdecchia et al.   HYPERTENSION

Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome

(2009) Umer Saleem et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Diagnostic Thresholds for Ambulatory Blood Pressure Moving Lower: A Review Based on a Meta-Analysis—Clinical Implications

(2008) Tine W. Hansen et al.   Journal of Clinical Hypertension